Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1215

1.

Focus on Internal Urethrotomy as Primary Treatment for Untreated Bulbar Urethral Strictures: Results from a Multivariable Analysis.

Barbagli G, Fossati N, Montorsi F, Balò S, Rimondi C, Larcher A, Sansalone S, Butnaru D, Lazzeri M.

Eur Urol Focus. 2018 Nov 5. pii: S2405-4569(18)30315-8. doi: 10.1016/j.euf.2018.10.014. [Epub ahead of print]

PMID:
30409684
2.

Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes.

Gandaglia G, Soligo M, Battaglia A, Muilwijk T, Robesti D, Mazzone E, Barletta F, Fossati N, Moschini M, Bandini M, Joniau S, Karnes RJ, Montorsi F, Briganti A.

Eur Urol. 2018 Nov 5. pii: S0302-2838(18)30837-6. doi: 10.1016/j.eururo.2018.10.042. [Epub ahead of print]

PMID:
30409676
3.

Corrigendum re "Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study" [Eur Urol 2012;62:797-802].

Colombo R, Rocchini L, Suardi N, Benigni F, Colciago G, Bettiga A, Pellucchi F, Maccagnano C, Briganti A, Salonia A, Rigatti P, Montorsi F.

Eur Urol. 2018 Nov 5. pii: S0302-2838(18)30662-6. doi: 10.1016/j.eururo.2018.09.012. [Epub ahead of print] No abstract available.

PMID:
30409675
4.

Rates of Positive Surgical Margins and Their Effect on Cancer-specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer.

Preisser F, Mazzone E, Knipper S, Nazzani S, Bandini M, Shariat SF, Tian Z, Saad F, Montorsi F, Zorn KC, Graefen M, Tilki D, Karakiewicz PI.

Clin Genitourin Cancer. 2018 Oct 4. pii: S1558-7673(18)30581-0. doi: 10.1016/j.clgc.2018.09.024. [Epub ahead of print]

PMID:
30366880
5.

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study.

Necchi A, Anichini A, Raggi D, Briganti A, Massa S, Lucianò R, Colecchia M, Giannatempo P, Mortarini R, Bianchi M, Farè E, Monopoli F, Colombo R, Gallina A, Salonia A, Messina A, Ali SM, Madison R, Ross JS, Chung JH, Salvioni R, Mariani L, Montorsi F.

J Clin Oncol. 2018 Oct 20:JCO1801148. doi: 10.1200/JCO.18.01148. [Epub ahead of print]

PMID:
30343614
6.

Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study.

Bandini M, Nazzani S, Marchioni M, Preisser F, Tian Z, Moschini M, Abdollah F, Suardi N, Graefen M, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2018 Sep 22. pii: S1558-7673(18)30185-X. doi: 10.1016/j.clgc.2018.09.011. [Epub ahead of print]

PMID:
30342845
7.

A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.

Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M, Robesti D, Dell'Oglio P, Moschini M, Zamboni S, Rakauskas A, De Cobelli F, Porpiglia F, Montorsi F, Briganti A.

Eur Urol. 2018 Oct 17. pii: S0302-2838(18)30753-X. doi: 10.1016/j.eururo.2018.10.012. [Epub ahead of print]

PMID:
30342844
8.

Re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2.

Montorsi F, Gandaglia G.

Eur Urol. 2018 Oct 16. pii: S0302-2838(18)30733-4. doi: 10.1016/j.eururo.2018.09.044. [Epub ahead of print] No abstract available.

PMID:
30340783
9.

The effect of race on survival after local therapy in metastatic prostate cancer patients.

Mazzone E, Bandini M, Preisser F, Nazzani S, Tian Z, Abdollah F, Soulieres D, Graefen M, Montorsi F, Shariat S, Saad F, Briganti A, Karakiewicz P.

Can Urol Assoc J. 2018 Oct 15. doi: 10.5489/cuaj.5399. [Epub ahead of print]

PMID:
30332592
10.

Undiagnosed prediabetes is highly prevalent in primary infertile men - results from a cross-sectional study.

Boeri L, Capogrosso P, Ventimiglia E, Pederzoli F, Frego N, Cazzaniga W, Chierigo F, Alfano M, Piemonti L, Viganò P, Pontillo M, Montanari E, Montorsi F, Salonia A.

BJU Int. 2018 Oct 16. doi: 10.1111/bju.14558. [Epub ahead of print]

11.

Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study.

Pozzi E, Capogrosso P, Chierigo F, Pederzoli F, Ventimiglia E, Boeri L, Frego N, Moretti D, Dehò F, Montorsi F, Salonia A.

Eur Urol Focus. 2018 Oct 10. pii: S2405-4569(18)30296-7. doi: 10.1016/j.euf.2018.10.003. [Epub ahead of print]

PMID:
30316826
12.

Regional differences in total hospital charges between open and robotically assisted radical prostatectomy in the United States.

Preisser F, Nazzani S, Mazzone E, Knipper S, Bandini M, Tian Z, Haese A, Saad F, Zorn KC, Montorsi F, Shariat SF, Graefen M, Tilki D, Karakiewicz PI.

World J Urol. 2018 Oct 12. doi: 10.1007/s00345-018-2525-y. [Epub ahead of print]

PMID:
30315358
13.

Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.

Fossati N, Suardi N, Gandaglia G, Bravi CA, Soligo M, Karnes RJ, Shariat S, Battaglia A, Everaerts W, Joniau S, Van Poppel H, Rajarubendra N, Gill IS, Larcher A, Mottrie A, Schmautz M, Heidenreich A, Kalz A, Osmonov D, Juenemann KP, Herlemann A, Gratzke C, Stief C, Montorsi F, Briganti A.

Eur Urol. 2018 Oct 6. pii: S0302-2838(18)30659-6. doi: 10.1016/j.eururo.2018.09.009. [Epub ahead of print]

PMID:
30301694
14.

External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.

Moschini M, Zaffuto E, Karakiewicz PI, Andrea DD, Foerster B, Abufaraj M, Soria F, Mattei A, Montorsi F, Briganti A, Shariat SF.

Eur Urol. 2018 Oct 4. pii: S0302-2838(18)30722-X. doi: 10.1016/j.eururo.2018.09.034. [Epub ahead of print]

PMID:
30293908
15.

Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.

Necchi A, Pond GR, Moschini M, Plimack ER, Niegisch G, Yu EY, Bamias A, Agarwal N, Vaishampayan U, Theodore C, Sridhar SS, Rosenberg JE, Bellmunt J, Gallina A, Colombo R, Montorsi F, Briganti A, Galsky MD.

Clin Genitourin Cancer. 2018 Sep 13. pii: S1558-7673(18)30482-8. doi: 10.1016/j.clgc.2018.09.008. [Epub ahead of print]

PMID:
30292628
16.

The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer.

Moschini M, Zaffuto E, Karakiewicz P, Mattei A, Gandaglia G, Fossati N, Montorsi F, Briganti A, Shariat SF.

World J Urol. 2018 Oct 1. doi: 10.1007/s00345-018-2504-3. [Epub ahead of print]

PMID:
30276543
17.

Intratunical Injection of Stromal vascular fraction prevents Fibrosis in a Rat Model of Peyronie's Disease.

Castiglione F, Hedlund P, Weyne E, Hakim L, Montorsi F, Salonia A, Bivalacqua TJ, De Ridder D, Milenkovic U, Ralph D, Garaffa G, Muneer A, Joniau S, Albersen M; Trauma and Reconstructive Urology Working Party of the European Association of Urology (EAU) Young Academic Urologists (YAU).

BJU Int. 2018 Sep 29. doi: 10.1111/bju.14570. [Epub ahead of print]

PMID:
30267556
18.

The Learning Curve for Robot-assisted Partial Nephrectomy: Impact of Surgical Experience on Perioperative Outcomes.

Larcher A, Muttin F, Peyronnet B, De Naeyer G, Khene ZE, Dell'Oglio P, Ferreiro C, Schatteman P, Capitanio U, D'Hondt F, Montorsi F, Bensalah K, Mottrie A.

Eur Urol. 2018 Sep 19. pii: S0302-2838(18)30644-4. doi: 10.1016/j.eururo.2018.08.042. [Epub ahead of print]

PMID:
30243798
19.

Do We Truly Care About the Functional Outcomes for Renal Cancer Patients? Multidisciplinarity Is Still Far Away.

Capitanio U, Larcher A, Kriegmair MC, Bertolo R, Salagierski M, Campi R, Klatte T, Trevisani F, Montorsi F, Mir MC, Ouzaid I; Kidney Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology.

Eur Urol. 2018 Sep 17. pii: S0302-2838(18)30642-0. doi: 10.1016/j.eururo.2018.08.040. [Epub ahead of print] No abstract available.

PMID:
30237026
20.

Treatments of 1242 bulbar urethral strictures: multivariable statistical analysis of results.

Barbagli G, Montorsi F, Balò S, Sansalone S, Loreto C, Butnaru D, Bini V, Lazzeri M.

World J Urol. 2018 Sep 15. doi: 10.1007/s00345-018-2481-6. [Epub ahead of print]

PMID:
30220045
21.

Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node metastases.

Moschini M, Zamboni S, Mattei A, Martini A, Zaffuto E, Briganti A, Gallina A, Montorsi F.

Transl Androl Urol. 2018 Aug;7(4):742-744. doi: 10.21037/tau.2018.07.03. No abstract available.

22.

Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.

Mazzone E, Nazzani S, Preisser F, Tian Z, Marchioni M, Bandini M, Capitanio U, Kapoor A, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, I Karakiewicz P.

Cancer Epidemiol. 2018 Oct;56:118-125. doi: 10.1016/j.canep.2018.08.006. Epub 2018 Aug 30.

PMID:
30173050
23.

Attitude towards active surveillance: a cross-sectional survey among patients with uroandrological disorders.

Capogrosso P, Boeri L, Ventimiglia E, Camozzi I, Cazzaniga W, Chierigo F, Scano R, Briganti A, Montorsi F, Salonia A.

BMJ Open. 2018 Aug 29;8(8):e022495. doi: 10.1136/bmjopen-2018-022495.

24.

Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.

Preisser F, Nazzani S, Bandini M, Marchioni M, Tian Z, Saad F, Chun FK, Shariat SF, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Int J Urol. 2018 Nov;25(11):929-936. doi: 10.1111/iju.13780. Epub 2018 Aug 26.

PMID:
30146729
25.

Temporal Trend in Incidental Prostate Cancer Detection at Surgery for Benign Prostatic Hyperplasia.

Capogrosso P, Capitanio U, Vertosick EA, Ventimiglia E, Chierigo F, Oreggia D, Moretti D, Briganti A, Vickers AJ, Montorsi F, Salonia A.

Urology. 2018 Aug 20. pii: S0090-4295(18)30783-0. doi: 10.1016/j.urology.2018.07.028. [Epub ahead of print]

PMID:
30138683
26.

Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma.

Antonelli A, Minervini A, Sandri M, Bertini R, Bertolo R, Carini M, Furlan M, Larcher A, Mantica G, Mari A, Montorsi F, Palumbo C, Porpiglia F, Romagnani P, Simeone C, Terrone C, Capitanio U.

Eur Urol. 2018 Nov;74(5):661-667. doi: 10.1016/j.eururo.2018.07.029. Epub 2018 Aug 10.

PMID:
30104082
27.

Multiple PDE5Is use as a marker of decreased overall men's health: A real-life study.

Oreggia D, Ventimiglia E, Capogrosso P, Boeri L, Cazzaniga W, Pederzoli F, Chierigo F, Dehò F, Montorsi F, Salonia A.

PLoS One. 2018 Aug 10;13(8):e0201601. doi: 10.1371/journal.pone.0201601. eCollection 2018.

29.

High Blood Pressure Is a Highly Prevalent but Unrecognised Condition in Primary Infertile Men: Results of a Cross-sectional Study.

Cazzaniga W, Capogrosso P, Ventimiglia E, Pederzoli F, Boeri L, Frego N, Abbate C, Alfano M, Viganò P, Montorsi F, Salonia A.

Eur Urol Focus. 2018 Aug 3. pii: S2405-4569(18)30214-1. doi: 10.1016/j.euf.2018.07.030. [Epub ahead of print]

PMID:
30082228
30.

Unrecognized Prediabetes Is Highly Prevalent in Men With Erectile Dysfunction-Results From a Cross-Sectional Study.

Boeri L, Capogrosso P, Pederzoli F, Ventimiglia E, Frego N, Chierigo F, Montanari E, Montorsi F, Salonia A.

J Sex Med. 2018 Aug;15(8):1117-1124. doi: 10.1016/j.jsxm.2018.06.009.

PMID:
30078463
31.

mTORC1 Upregulation Leads to Accumulation of the Oncometabolite Fumarate in a Mouse Model of Renal Cell Carcinoma.

Drusian L, Nigro EA, Mannella V, Pagliarini R, Pema M, Costa ASH, Benigni F, Larcher A, Chiaravalli M, Gaude E, Montorsi F, Capitanio U, Musco G, Frezza C, Boletta A.

Cell Rep. 2018 Jul 31;24(5):1093-1104.e6. doi: 10.1016/j.celrep.2018.06.106.

32.

Predictive and prognostic effect of inflammatory lymphadenopathies in renal cell carcinoma.

Muttin F, Pecoraro A, Larcher A, Dell'Oglio P, Nini A, Cianflone F, Trevisani F, Dehò F, Briganti A, Salonia A, Montorsi F, Bertini R, Capitanio U.

World J Urol. 2018 Jul 25. doi: 10.1007/s00345-018-2412-6. [Epub ahead of print]

PMID:
30046844
33.

Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer.

Preisser F, Mazzone E, Nazzani S, Bandini M, Tian Z, Marchioni M, Steuber T, Saad F, Montorsi F, Shariat SF, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol. 2018 Jul 20. pii: S0302-2838(18)30484-6. doi: 10.1016/j.eururo.2018.07.006. [Epub ahead of print]

PMID:
30037529
34.

Robotic laparoendoscopic single-site radical prostatectomy (R-LESS-RP) with daVinci Single-Site® platform. Concept and evolution of the technique following an IDEAL phase 1.

Gaboardi F, Pini G, Suardi N, Montorsi F, Passaretti G, Smelzo S.

J Robot Surg. 2018 Jul 17. doi: 10.1007/s11701-018-0839-9. [Epub ahead of print]

PMID:
30019228
35.

Re: Exercise and Cancer Treatment: Balancing Patient Needs. Lancet Oncol 2018;19:715: Cancer Prevention and Treatment: More than Exercising.

Lavorgna G, Montorsi F, Salonia A.

Eur Urol. 2018 Nov;74(5):e122-e123. doi: 10.1016/j.eururo.2018.06.038. Epub 2018 Jul 14. No abstract available.

PMID:
30017406
36.

Simultaneous Bilateral Endoscopic Surgery (SBES) for Patients with Bilateral Upper Tract Urolithiasis: Technique and Outcomes.

Giusti G, Proietti S, Rodríguez-Socarrás ME, Eisner BH, Saitta G, Mantica G, Villa L, Salonia A, Montorsi F, Gaboardi F.

Eur Urol. 2018 Jul 14. pii: S0302-2838(18)30462-7. doi: 10.1016/j.eururo.2018.06.034. [Epub ahead of print]

PMID:
30017401
38.

Clinical and pathological characteristics of a series of patients with newly diagnosed primary renal liposarcoma: natural history and effect on survival.

Fichera D, Luciano R, Nini A, Freschi M, Doglioni C, Bertini R, Montorsi F, Capitanio U.

Arch Esp Urol. 2018 Jul;71(6):555-558. Review.

PMID:
29991665
39.

Pathological High-risk Renal Cell Carcinoma: Trends in Clinical Characteristics Over 25 Years.

DI Trapani E, Dell'oglio P, Larcher A, Nini A, Muttin F, Cianflone F, Dehò F, Matloob R, DI Trapani D, Freschi M, Salonia A, Briganti A, Montorsi F, Bertini R, Capitanio U.

Anticancer Res. 2018 Jul;38(7):4123-4130. doi: 10.21873/anticanres.12703.

PMID:
29970539
40.

Phase I and phase II clinical trials for the treatment of male sexual dysfunction-a systematic review of the literature.

Capogrosso P, Montorsi F, Salonia A.

Expert Opin Investig Drugs. 2018 Jul;27(7):583-593. doi: 10.1080/13543784.2018.1495707. Epub 2018 Jul 11. Review.

PMID:
29969332
41.

Location of Metastases in Contemporary Prostate Cancer Patients Affects Cancer-Specific Mortality.

Mazzone E, Preisser F, Nazzani S, Tian Z, Bandini M, Gandaglia G, Fossati N, Soulières D, Graefen M, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Clin Genitourin Cancer. 2018 Oct;16(5):376-384.e1. doi: 10.1016/j.clgc.2018.05.016. Epub 2018 Jun 5.

PMID:
29954690
42.

Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy.

Dell'Oglio P, Stabile A, Dias BH, Gandaglia G, Mazzone E, Fossati N, Cucchiara V, Zaffuto E, Mirone V, Suardi N, Mottrie A, Montorsi F, Briganti A.

World J Urol. 2018 Jun 9. doi: 10.1007/s00345-018-2360-1. [Epub ahead of print]

PMID:
29948044
43.

Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018.

Briganti A, Fossati N, Catto JWF, Cornford P, Montorsi F, Mottet N, Wirth M, Van Poppel H.

Eur Urol. 2018 Sep;74(3):357-368. doi: 10.1016/j.eururo.2018.06.008. Epub 2018 Jun 22.

PMID:
29937198
44.

Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection.

Preisser F, Nazzani S, Bandini M, Marchioni M, Tian Z, Montorsi F, Saad F, Briganti A, Steuber T, Budäus L, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Urol Oncol. 2018 Aug;36(8):365.e1-365.e7. doi: 10.1016/j.urolonc.2018.05.019. Epub 2018 Jun 7.

PMID:
29887241
45.

Testicular microbiome in azoospermic men-first evidence of the impact of an altered microenvironment.

Alfano M, Ferrarese R, Locatelli I, Ventimiglia E, Ippolito S, Gallina P, Cesana D, Canducci F, Pagliardini L, Viganò P, Clementi M, Nebuloni M, Montorsi F, Salonia A.

Hum Reprod. 2018 Jul 1;33(7):1212-1217. doi: 10.1093/humrep/dey116.

46.

Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results database.

Preisser F, Bandini M, Mazzone E, Nazzani S, Marchioni M, Tian Z, Saad F, Pompe RS, Shariat SF, Heinzer H, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Focus. 2018 May 22. pii: S2405-4569(18)30123-8. doi: 10.1016/j.euf.2018.05.006. [Epub ahead of print]

PMID:
29802052
47.

Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort.

Marra G, Gontero P, Brattoli M, Filippini C, Capitanio U, Montorsi F, Daneshmand S, Huang WC, Linares Espinós E, Martínez-Salamanca JI, McKiernan JM, Zigeuner R, Libertino JA.

Urol Oncol. 2018 Jul;36(7):339.e1-339.e8. doi: 10.1016/j.urolonc.2018.04.007. Epub 2018 May 24.

PMID:
29801993
48.

Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group).

Bertolo R, Autorino R, Simone G, Derweesh I, Garisto JD, Minervini A, Eun D, Perdona S, Porter J, Rha KH, Mottrie A, White WM, Schips L, Yang B, Jacobsohn K, Uzzo RG, Challacombe B, Ferro M, Sulek J, Capitanio U, Anele UA, Tuderti G, Costantini M, Ryan S, Bindayi A, Mari A, Carini M, Keehn A, Quarto G, Liao M, Chang K, Larcher A, De Naeyer G, De Cobelli O, Berardinelli F, Zhang C, Langenstroer P, Kutikov A, Chen D, De Luyk N, Sundaram CP, Montorsi F, Stein RJ, Haber GP, Hampton LJ, Dasgupta P, Gallucci M, Kaouk J, Porpiglia F.

Eur Urol. 2018 Aug;74(2):226-232. doi: 10.1016/j.eururo.2018.05.004. Epub 2018 May 19.

PMID:
29784191
49.

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.

Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, Vickers AJ.

Eur Urol. 2018 Aug;74(2):197-203. doi: 10.1016/j.eururo.2018.05.003. Epub 2018 May 16.

PMID:
29778349
50.

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.

Gandaglia G, van den Bergh RCN, Tilki D, Fossati N, Ost P, Surcel CI, Sooriakumaran P, Tsaur I, Valerio M, Kretschmer A, Zaffuto E, Salomon L, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Ploussard G; European Association of Urology Young Academic Urologists Working Party on Prostate Cancer (EAU-YAUWP).

BJU Int. 2018 Nov;122(5):823-830. doi: 10.1111/bju.14391. Epub 2018 Jun 3.

PMID:
29772103

Supplemental Content

Loading ...
Support Center